Lilly seeks investors to expand subsidiary's portfolio
Eli Lilly and Co. plans to increase funds and put more drug candidates into its subsidiary Chorus, a company executive said. The drugmaker is looking for financial backers rather than pharmaceutical partners to maintain its control over Chorus' early- and late-stage drug development, said Gino Santini, Lilly's senior vice president of corporate strategy and business development.
Wall Street Journal, The | 11/03
This story published in BIO SmartBrief on 11/04/2009
More from SmartBrief:
FDA clears prasugrel, requires black-box warning
Monday, July 13, 2009
Lilly's Cymbalta helps fill financial gap left by Prozac
Monday, August 24, 2009
Lilly to reduce workforce by nearly 14%
Monday, September 21, 2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|